Completed NA INTERVENTIONAL 1-arm NCT03735329

Polso SpO2 Accuracy Validation Study

Sponsor: ChroniSense Medical Ltd.

Conditions Hypoxia

Updated 6 times since 2018 Last updated: Feb 4, 2019 Started: Jan 29, 2019 Primary completion: Jan 31, 2019 Completion: Feb 4, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03735329, this NA trial focuses on Hypoxia and remains completed. Sponsored by ChroniSense Medical Ltd., it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA
Mar 2019 — Feb 2020 [monthly]

Completed NA

Status: Not Yet Recruiting → Completed

▶ Show 1 earlier version

Dec 2018 — Mar 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ChroniSense Medical Ltd.

Data source: ChroniSense Medical Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Louisville, United States